Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes

Détails

ID Serval
serval:BIB_5795C60A1FF3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes
Périodique
Diabetologia
Auteur⸱e⸱s
Ruiz  J., Thillet  J., Huby  T., James  R. W., Erlich  D., Flandre  P., Froguel  P., Chapman  J., Passa  P.
ISSN
0012-186X
Statut éditorial
Publié
Date de publication
06/1994
Volume
37
Numéro
6
Pages
585-91
Notes
95011113
0012-186x
Journal Article --- Old month value: Jun --- Old uritopublisher value: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7926343
Résumé
Non-insulin-dependent diabetes mellitus (NIDDM) is a strong and independent risk factor for coronary heart disease. We assessed the potential relationship between plasma Lp(a) levels, apo(a) phenotypes and coronary heart disease in a population of NIDDM patients. Seventy-one patients with coronary heart disease, who previously have had transmural myocardial infarction, or significant stenosis on coronary angiography, or positive myocardial thallium scintigraphy, or in combination, were compared with 67 patients without coronary heart disease, who tested negatively upon either coronary angiography, myocardial thallium scintigraphy or a maximal exercise test. The prevalence of plasma Lp(a) levels elevated above the threshold for increased cardiovascular risk (> 0.30 g/l) was significantly higher (p = 0.005) in patients with coronary heart disease (33.8%) compared to the control group (13.4%). The relative risk (odds ratio) of coronary heart disease among patients with high Lp(a) concentrations was 3.1 (95% confidence interval, 1.31-7.34; p = 0.01). The overall frequency distribution of apo(a) phenotypes differed significantly between the two groups (p = 0.043). However, the frequency of apo(a) isoforms of low apparent molecular mass (< or = 700 kDa) was of borderline significance (p = 0.067) between patients with or without coronary heart disease (29.6% and 16.4%, respectively). In this Caucasian population of NIDDM patients, elevated Lp(a) levels were associated with coronary heart disease, an association which was partially accounted for by the higher frequency of apo(a) isoforms of small size. In multivariate analyses, elevated levels of Lp(a) were independently associated with coronary heart disease (odds ratio 3.48, p = 0.0233).
Mots-clé
Apolipoproteins A/*analysis/*classification Blood Pressure Case-Control Studies Coronary Disease/*blood/ethnology/etiology Diabetes Mellitus, Non-Insulin-Dependent/*blood/complications/ethnology Female Human Lipoprotein(a)/*blood Male Middle Age Odds Ratio Phenotype Regression Analysis Risk Factors Support, Non-U.S. Gov't
Pubmed
Web of science
Création de la notice
03/03/2008 16:15
Dernière modification de la notice
20/08/2019 15:11
Données d'usage